In Fischer J, Ganellin CR (eds.)
Medication Guidelines for GLP-1 Receptor Agonists
Could another medicine be worsening constipation, nausea, or reflux
Around 3 months: Tirzepatide: about 8% Wegovy : about 5% Around 6 months: Tirzepatide: about 15% Wegovy : about 10.5% 1 year and beyond: Tirzepatide: about 21% Wegovy : about 15% These results are from people who reached the highest approved doses used in studies: 15 mg for tirzepatide and 2.4 mg for Wegovy (semaglutide)
Additionally, pharmaceutical interventions such as atorvastatin have demonstrated efficacy in addressing insulin resistance, elevated cholesterol levels, hyperandrogenism, and ovarian dysfunction [144]
The Journal of clinical endocrinology and metabolism , 91 (3), 799805